Efficacy and safety of central compartment neck dissection for recurrent thyroid carcinoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 138, Issue 1, 2012, Pages 33-37

  Shah, Manish D ^a   Harris, Luke D ^a   Nassif, Ramez G ^a   Kim, Dae ^a   Eski, Spiro ^a   Freeman, Jeremy L ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE; SODIUM IODIDE I 131; THYROGLOBULIN;

ADULT; AGED; ARTICLE; CANCER CONTROL; FEMALE; HUMAN; HYPOPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NECK DISSECTION; PARATHYROID HORMONE BLOOD LEVEL; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; RECURRENT CANCER; RECURRENT LARYNGEAL NERVE INJURY; RETROSPECTIVE STUDY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; PATIENT SAFETY; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 84862927043     PISSN: 08864470     EISSN: 1538361X     Source Type: Journal    
DOI: 10.1001/archoto.2011.223     Document Type: Article

References (17)

1. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer. 1998;83(12):2638-2648. (Pubitemid 29019586)
2. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002;26(8):879-885. (Pubitemid 36920280)
3. Clayman GL, Shellenberger TD, Ginsberg LE, et al. Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma. Head Neck. 2009;31(9):1152-1163.
4. Kim MK, Mandel SH, Baloch Z, et al. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer. Arch Otolaryngol Head Neck Surg. 2004;130(10):1214-1216. (Pubitemid 39371970)
5. Palme CE, Freeman JL. Surgical strategy for thyroid bed recurrence in patients with well-differentiated thyroid carcinoma. J Otolaryngol. 2005;34(1):7-12. (Pubitemid 40797350)
6. Schuff KG, Weber SM, Givi B, Samuels MH, Andersen PE, Cohen JI. Efficacy of nodal dissection for treatment of persistent/recurrent papillary thyroid cancer. Laryngoscope. 2008;118(5):768-775. (Pubitemid 351631273)
7. Robbins KT, Shaha AR, Medina JE, et al Committee for Neck Dissection Classification, American Head and Neck Society. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008;134(5):536-538. (Pubitemid 351724386)
8. Vescan A, Witterick I, Freeman J. Parathyroid hormone as a predictor of hypocalcemia after thyroidectomy. Laryngoscope. 2005;115(12):2105-2108. (Pubitemid 44391620)
9. Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104(6):947-953. (Pubitemid 19011971)
10. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am. 1990;19(3):545-576. (Pubitemid 20282656)
11. Hay ID, Bergstralh EJ, Grant CS, et al. Impact of primary surgery on outcome in 300 patients with pathologic tumor-node-metastasis stage III papillary thyroid carcinoma treated at one institution from 1940 through 1989. Surgery. 1999;126(6):1173-1182.
12. Kim BM, Kim MJ, Kim EK, Park SI, Park CS, Chung WY. Controlling recurrent papillary thyroid carcinoma in the neck by ultrasonography-guided percutaneous ethanol injection. Eur Radiol. 2008;18(4):835-842. (Pubitemid 351447779)
13. Lewis BD, Hay ID, Charboneau JW, McIver B, Reading CC, Goellner JR. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol. 2002;178(3):699-704. (Pubitemid 34178153)
14. Sippel RS, Chen H. Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid. 2009;19(12):1373-1380.
15. Farrag TY, Agrawal N, Sheth S, et al. Algorithm for safe and effective reoperative thyroid bed surgery for recurrent/persistent papillary thyroid carcinoma. Head Neck. 2007;29(12):1069-1074.
16. Shen WT, Ogawa L, Ruan D, et al. Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. Arch Surg. 2010;145(3):272-275.
17. Mazzaferri EL, Doherty GM, Steward DL. The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid. 2009;19(7):683-689.